Volume 43, Issue 12 , Pages 1506-1515, December 2004
Attention-Deficit/Hyperactivity Disorder and Comorbidities in 18 Paisa Colombian Multigenerational Families
ABSTRACT
Objective:
Eighteen extended multigenerational families were recruited from the genetically isolated Paisa community in Colombia to conduct genetic studies of attention-deficit/hyperactivity disorder (ADHD). This report describes the inclusion strategy and clinical features of participants to facilitate comparisons with other data sets.
Method:
Families were selected through a fixed-sampling scheme beginning with child probands referred for clinical evaluation for ADHD. Direct structured psychiatric interviews were conducted with 433 informative individuals, including 92 children aged 4 to 11, 57 adolescents aged 12 to 17, and 284 adults. Best estimate ADHD diagnoses were established for each informative pedigree member.
Results:
These families contained a high proportion of individuals affected with ADHD (32.8%), which was highly comorbid with conduct disorder (50%; odds ratio 11.5, 95% confidence interval = 6.4–20.9), oppositional defiant disorder (25.4%; odds ratio 2.7, confidence interval = 1.5–4.8), and associated conditions including nicotine dependence and alcohol abuse and/or dependence.
Conclusions:
ADHD in these extended Paisa families is highly comorbid with conduct and oppositional defiant disorders. This pattern of comorbidity, as well as the large dense pedigrees of the sample, suggests that it will be particularly useful for molecular genetic studies that are currently under way.
Key Words: attention-deficit/hyperactivity disorder , comorbidity , conduct disorder , genetics , phenotype , population isolate
To access this article, please choose from the options below
This research was supported by the Instituto Colombiano para el Desarrollo de la Ciencia y Tecnología (Colciencias) that funded the project: Fenotipo del Trastorno de la Atención y su Comorbilidad en Familias y en la Población General de una Comunidad Antioqueña, Colciencias Project Code 115-04-12010, grant 115-2002, and by funds provided by the Intramural Research Programs of the National Human Genome Research Institute and the National Institute of Mental Health.Disclosure: Dr. Castellanos received grant support in 2003 and 2004 from McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil PPC, Inc. The other authors have no financial relationships to disclose.
PII: S0890-8567(09)61384-8
doi:10.1097/01.chi.0000142279.79805.dc
© 2004 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Volume 43, Issue 12 , Pages 1506-1515, December 2004
